Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Tema Oncology ETF
(NQ:
CANC
)
28.05
-0.24 (-0.85%)
Official Closing Price
Updated: 4:15 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tema Oncology ETF
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
April 25, 2024
The radiopharmaceuticals space could be worth up to $25 billion, according to one estimate.
Via
Investor's Business Daily
Healthcare ETFs For The Weight-Loss Drug Boom And Beyond
April 08, 2024
Two dominant investing themes over the past year have been AI and weight-loss drugs.
Via
Talk Markets
Topics
Artificial Intelligence
ETFs
Exposures
Artificial Intelligence
Biden's Million Dollar Moonshot - $240 Million Is A Boon For Cancer Research, Will it be a Boost For Pharma Stocks Too?
December 05, 2023
Via
Benzinga
EXCLUSIVE: Tema ETFs' Innovative Thematic Investing Approach Targets New Opportunities Beyond The Fads
December 01, 2023
Tema ETFs is redefining thematic investing, focusing on long-term structural trends & precision in security selection rather than chasing short-term fads.
Via
Benzinga
Topics
ETFs
Active ETFs Appear Booming In 2023 — Tema ETFs Are Taking Them Into A New Direction
November 28, 2023
The rapid emergence of the ETF industry, marked by its AuM growth from $1 trillion to $10 trillion this past decade, was driven by passive indexed funds which thrived in a low-rates, low-volatility...
Via
Benzinga
Topics
ETFs
Can Weight-Loss Drug Ozempic Tip The Scales For Tema's New Healthcare ETF?
November 21, 2023
New class of weight-reducing drugs underpin launch of exchange-traded fundTema launches healthcare ETF focused on companies researching and treating cardiovascular disease, obesity and diabetes,...
Via
Benzinga
Topics
ETFs
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.